These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2122080)
21. Glycogen storage disease type I. Results of treatment with frequent daytime feeding, combined with nocturnal intragastric feeding and with administration of an alpha-glucosidase inhibitor. Gröbe H; Ullrich K Eur J Pediatr; 1983 Apr; 140(2):102-4. PubMed ID: 6411473 [TBL] [Abstract][Full Text] [Related]
22. Continuous glucose for treatment of patients with type 1 glycogen-storage disease: comparison of the effects of dextrose and uncooked cornstarch on biochemical variables. Wolfsdorf JI; Plotkin RA; Laffel LM; Crigler JF Am J Clin Nutr; 1990 Dec; 52(6):1043-50. PubMed ID: 2239779 [TBL] [Abstract][Full Text] [Related]
23. Renal disease in type I glycogen storage disease. Chen YT; Coleman RA; Scheinman JI; Kolbeck PC; Sidbury JB N Engl J Med; 1988 Jan; 318(1):7-11. PubMed ID: 3422104 [TBL] [Abstract][Full Text] [Related]
24. Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production. Cohen JL; Vinik A; Faller J; Fox IH J Clin Invest; 1985 Jan; 75(1):251-7. PubMed ID: 2856925 [TBL] [Abstract][Full Text] [Related]
25. Renal disease in an adult with type 1 glycogen storage disease. Kiyama S; Kitamoto Y; Nakayama M; Fukui H; Arima S; Tomita M; Inoue T; Sato T Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):81-5. PubMed ID: 2038136 [TBL] [Abstract][Full Text] [Related]
26. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Lee PJ; Patel A; Hindmarsh PC; Mowat AP; Leonard JV Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500 [TBL] [Abstract][Full Text] [Related]
27. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk. Nagasaka H; Hirano K; Ohtake A; Miida T; Takatani T; Murayama K; Yorifuji T; Kobayashi K; Kanazawa M; Ogawa A; Takayanagi M Eur J Pediatr; 2007 Oct; 166(10):1009-16. PubMed ID: 17206455 [TBL] [Abstract][Full Text] [Related]
28. Effective renal plasma flow in patients with glycogen storage disease type I. Hahn-Ullrich H; Sciuk J; Bartenstein P; Kreysing P; Ullrich K Eur J Pediatr; 1993 Aug; 152(8):674-6. PubMed ID: 8404972 [TBL] [Abstract][Full Text] [Related]
29. Renal disease in an adult patient with type I glycogen storage disease. Lim PS; Kho B Ren Fail; 1995 Nov; 17(6):769-74. PubMed ID: 8771251 [TBL] [Abstract][Full Text] [Related]
30. [Relation between age, sex and various metabolic parameters: blood uric acid (4776 specimens), blood sugar (7211 specimens), blood cholesterol (5600 specimens) and blood triglycerides (4438 specimens)]. Marnini P; Zulian C Quad Sclavo Diagn; 1976 Dec; 12(4):416-30. PubMed ID: 1028091 [TBL] [Abstract][Full Text] [Related]
31. Hyperuricemia and dicarboxylicaciduria in glycogen storage disease. Dosman JA; Crawhill JC; Klassen GA; Mamer OA Adv Exp Med Biol; 1973; 41():361-6. PubMed ID: 4524742 [No Abstract] [Full Text] [Related]
32. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients. Nguyen AD; Pan CJ; Weinstein DA; Chou JY Mol Genet Metab; 2006 Nov; 89(3):233-8. PubMed ID: 16777453 [TBL] [Abstract][Full Text] [Related]
33. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III. Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362 [TBL] [Abstract][Full Text] [Related]
34. Renal involvement in type I glycogen storage disease. Report of one case. Lara A; Armas JR; Marti V; Hevia A; Jarava C; Palma A Nephrol Dial Transplant; 1994; 9(8):1179-81. PubMed ID: 7800223 [No Abstract] [Full Text] [Related]
36. Urinary excretion of C6-C10 dicarboxylic acids in glycogen storage disease types I and 3. Dosman J; Crawhall JC; Klassen GA; Mamer OA; Neumann P Clin Chim Acta; 1974 Feb; 51(1):93-101. PubMed ID: 4522834 [No Abstract] [Full Text] [Related]
37. A teenager with a hepatic filling defect. Sanders K Hosp Pract (Off Ed); 1984 Jul; 19(7):110C, 110I, 110L passim. PubMed ID: 6429162 [No Abstract] [Full Text] [Related]
38. Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a. Bandsma RH; Rake JP; Visser G; Neese RA; Hellerstein MK; van Duyvenvoorde W; Princen HM; Stellaard F; Smit GP; Kuipers F J Pediatr; 2002 Feb; 140(2):256-60. PubMed ID: 11865283 [TBL] [Abstract][Full Text] [Related]
39. [Formation of platelet thromboxane in a patient with type I glycogenosis]. Strano A; Davì G; Averna M; Benigno V; D'Alessandro G; La Grutta A; Notarbartolo A Recenti Prog Med; 1985 Dec; 76(12):619-22. PubMed ID: 3868788 [No Abstract] [Full Text] [Related]
40. Hypertension in a child with type IA glycogen storage disease. Jonas AJ; Verani RR; Howell RR; Conley SB Am J Kidney Dis; 1988 Mar; 11(3):264-6. PubMed ID: 3422787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]